Open Access
Low neural exosomal levels of cellular survival factors in Alzheimer's disease
Author(s) -
Goetzl Edward J.,
Boxer Adam,
Schwartz Janice B.,
Abner Erin L.,
Petersen Ronald C.,
Miller Bruce L.,
Carlson Olga D.,
Mustapic Maja,
Kapogiannis Dimitrios
Publication year - 2015
Publication title -
annals of clinical and translational neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.824
H-Index - 42
ISSN - 2328-9503
DOI - 10.1002/acn3.211
Subject(s) - gene silencing , medicine , transcription factor , alzheimer's disease , frontotemporal dementia , microvesicles , disease , repressor , dementia , cancer research , oncology , endocrinology , microrna , biology , genetics , gene
Abstract Transcription factors that mediate neuronal defenses against diverse stresses were quantified in plasma neural‐derived exosomes of Alzheimer's disease or frontotemporal dementia patients and matched controls. Exosomal levels of low‐density lipoprotein receptor‐related protein 6, heat‐shock factor‐1, and repressor element 1‐silencing transcription factor all were significantly lower in Alzheimer's disease patients than controls ( P < 0.0001). In frontotemporal dementia, the only significant difference was higher levels of repressor element 1‐silencing transcription factor than in controls. Exosomal transcription factors were diminished 2–10 years before clinical diagnosis of Alzheimer's disease. Low exosomal levels of survival proteins may explain decreased neuronal resistance to Alzheimer's disease neurotoxic proteins.